A phase II trial of GDC-0084 for Glioblastoma.
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2016
At a glance
- Drugs GDC 0084 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 11 Nov 2016 New trial record
- 30 Oct 2016 According to a Novogen media release, company plans to initiate this trial in 2017.